Navigation Links
Celsion Corporation Announces Combined Clinical Data from Two Phase I Trials to be Presented at the 2013 San Antonio Breast Cancer Conference
Date:9/9/2013

failed previous treatment regimens including chemotherapy and radiation therapy.  The cancer has now appeared on their chest wall and the patients are faced with limited or no treatment options.  Breast cancer recurrence at the chest wall is difficult to treat and is characterized by disfigurement, pain and restriction of movement," said Dr. Nicholas Borys, Celsion's Vice President and Chief Medical Officer. "The data from these two Phase I studies provides strong evidence of ThermoDox's broad potential clinical value across different cancers, including the ability to provide a new tool against aggressive, superficial tumors. We look forward to rapidly recruiting patients for the Phase 2 portion of the DIGNITY Study."

About Celsion Corporation

Celsion is a leading oncology company dedicated to the development and commercialization of innovative cancer drugs including tumor-targeting treatments using focused heat energy in combination with heat-activated liposomal drug technology. Celsion has research, license, or commercialization agreements with leading institutions including the National Institutes of Health, Duke University Medical Center, University of Hong Kong, the University of Pisa, the UCLA Department of Medicine, the Kyungpook National University Hospital, the Beijing Cancer Hospital and the University of Oxford.

For more information on Celsion, visit our website: http://www.celsion.com.

Celsion wishes to inform readers that forward-looking statements in this release are made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Readers are cautioned that such forward-looking statements involve risks and uncertainties including, without limitation, unforeseen changes in the course of res
'/>"/>

SOURCE Celsion Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Celsion Corporation Reports Second Quarter 2013 Financial Results and Provides HEAT Study Update
2. Celsion Corporation to Hold Second Quarter 2013 Financial Results Conference Call on Thursday, August 8, 2013
3. Celsion Corporation Issues Statement Regarding Misleading Blog Entry
4. Celsion Corporation Reports Year End 2012 Financial Results and Provides Business Update
5. Celsion Corporation to Hold Year-End 2012 Financial Results Conference Call On Monday, March 18, 2013
6. The X-Change Corporation To Announce Corporate Name Change Next Week; New Industry-Driven Branding to Commence For Global Activities, Services, Product Lines, and Website
7. Unilife Corporation To Announce Financial Results For Fiscal Year 2013 Fourth Quarter And Year End On Tuesday, September 10, 2013
8. Arrayit Corporation Holds Successful Meeting with DHK Medical Products CEO
9. MGC Diagnostics Corporation Reports 2013 Third Quarter Operating Results
10. Immune Pharmaceuticals Completes Merger with EpiCept Corporation
11. Luminex Corporation To Present At Morgan Stanley Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2015)... April 28, 2015   GenSpera, Inc. ... and Trademark Office has issued U.S. Patent No. ... claiming numerous compositions for the company,s prodrugs designed ... GenSpera is developing a series ... powerful cytotoxin isolated from the poisonous plant, ...
(Date:4/28/2015)... , April 28, 2015  Unfors RaySafe, the ... new radiation Survey sensor aimed at expanding the RaySafe ... X2 Survey sensor is the easiest and fastest solution ... It is the latest addition to the continually expanding ... to perform leakage and scatter measurements in diagnostic X-ray ...
(Date:4/28/2015)... 2015 /CNW/ - The group representing the living victims of ... a two-hour meeting with Health Canada officials in a ... Canada announced a $180 million support package for Thalidomide ... after the Health Canada announcement and five months after ... victims, the group representing Canada,s ...
Breaking Medicine Technology:GenSpera Granted New Patent for Prodrugs Activated by Prostate Specific Antigen 2Unfors RaySafe, a Fluke Biomedical company, unveils a new Survey sensor for the RaySafe X2 2Thalidomide Victims Gravely Concerned by Health Canada's Silence 2
... AAHC Calls for National Entity to Address Workforce ... center CEOs told congressional staff and representatives of ... that pending health reform legislation does not yet ... to implement successful health system reform. "Pending ...
... AMN Healthcare Services, Inc. (NYSE: AHS ), the ... its quarterly conference call to discuss third quarter results on ... company also expects to issue an earnings news release on ... approximately 4:00 p.m. Eastern Time. , A live webcast of ...
Cached Medicine Technology:Health Reform Bills Still Lack Strategic Focus on Health Workforce 2AMN Healthcare Services to Host 2009 Third Quarter Earnings Conference Call on Thursday, October 29, 2009 2
(Date:4/28/2015)... Santa Cruz, California (PRWEB) April 28, 2015 ... leader in premium, healthy, and convenient nutrition ... expansion of its distribution through United Natural ... distributor of natural, organic and specialty foods ... will now be available to thousands of ...
(Date:4/27/2015)... Churchview Supportive Living, a Gardant affordable ... and Fashion Show from 10:30 a.m. to noon on ... 2626 W. 63rd St. in Chicago, serves low-income older ... to maintain their independence. , “Mothers, grandmothers, godmothers and ... Day Brunch,” said Director of Marketing Elizabeth Clippard. , ...
(Date:4/27/2015)... (PRWEB) April 27, 2015 Women may ... from concussion, according to a new study published online ... mild traumatic brain injury (MTBI), is a common medical ... some individuals. , In most cases, patients who ... Ten to 15 percent of MTBI patients will continue ...
(Date:4/27/2015)... 2015 Jesse L. Goodman, M.D., M.P.H., ... Pharmacopeial Convention (USP) at the recently concluded Convention Meeting ... at Georgetown University and the Director of its Center ... As USP President, a volunteer position, Dr. Goodman will ... be a voting member, ex officio, of the Board ...
(Date:4/27/2015)... 27, 2015 Based in the Twin ... one of the few insurance marketing organizations in the ... and asset protection markets as well as employer sponsored ... afforded Secura Consultants the opportunity to consult with disability ... business easier and quicker. , An example of these ...
Breaking Medicine News(10 mins):Health News:LifeAID Beverage Co. Announces Expanded Distribution Roll Out Through UNFI -- United Natural Foods Inc. 2Health News:LifeAID Beverage Co. Announces Expanded Distribution Roll Out Through UNFI -- United Natural Foods Inc. 3Health News:Churchview Supportive Living Community in Chicago to Host Mother's Day Brunch 2Health News:Women Show Persistent Memory Impairment after Concussion 2Health News:Women Show Persistent Memory Impairment after Concussion 3Health News:Dr. Jesse Goodman Elected President of the USP Convention 2Health News:Simplified Solutions Now Makes Disability Insurance Business With Secura Consultants Even Easier! 2
... A recent research has found that the asthma epidemic in ... by adults over the past century . ,The study, ... is published this month in Annals of Allergy, Asthma & ... Asthma and Immunology (ACAAI). ,The pervasiveness of asthma ...
... a woman's reproductive history to start hormone therapy? How does ... is the most beneficial form of estrogen? ,These ... University of Wisconsin School of Medicine and Public Health hope ... of its kind, on the effects of estrogen therapy with ...
... tests using gene sequencing is able to help confirm ... the tools for much more accurate and rapid diagnosis. ... 40 inherited and potentially life-threatening disorders that cause enzymes ... to the accumulation of waste products that damage organs ...
... College London refutes the long-standing "runaway" theory on how HIV ... attacking T helper cells, a class of white blood cells ... long been puzzled as to why this process of depletion ... ,According to the "runaway" hypothesis, T cells infected ...
... documented the first case of virgin birth in cartilaginous fish, after ... aquarium, that had only female sharks which had no contact ... of the pup at Omaha's Henry Doorly Zoo, in the US, ... in one of the female sharks in the aquarium. ...
... Club of Calcutta will reach out to more poor people ... ,"All the three healthcare units we have opened in ... set a target to reach out to more number of ... functionary K.N. Gupta told a press conference Tuesday. ...
Cached Medicine News:Health News:Rise in Cigarette Use may Elucidate Asthma Epidemic in Children 2Health News:Effectiveness of Hormone Therapy During Menopause 2Health News:New DNA Tests Advances Treatment of Lysosomal Storage Diseases 2Health News:Study Refutes Theory on HIV's Effect on White Blood Cells 2
... as bone Gla protein, is a vitamin ... major component of the noncollagenous bone matrix ... bone, with a small amount produced by ... During bone formation, newly synthesized osteocalcin is ...
... Human Insulin-like growth factor binding protein-2 (IGFBP-2) ... IGFBPs have been proposed) which specifically bind ... IGF-II. The binding affinity of IGFBP-2 for ... than for IGF-I [1], suggesting a role ...
... produced in the adrenal gland and gonads, ... and estrone, both of which may be ... weak androgenic activity, estimated at ~(less than ... However, serum androstenedione levels often exceed testosterone ...
... Inhibins are heterodimeric proteins that suppress ... from the pituitary. Inhibin consists of two ... linked together. Inhibin A consists of the ... the alpha-subunit and betaB-subunit. Only the dimeric ...
Medicine Products: